Concord Biotech Ltd. (CONCORDBIO)

Overview

Concord Biotech Limited is a distinguished biopharmaceutical company that operates both domestically in India and on an international scale. The company has carved a niche for itself in the pharmaceutical industry through its commitment to research and development, manufacturing, marketing, and the sale of innovative pharmaceutical products. Since its inception in 1984 and with its headquarters located in Ahmedabad, India, Concord Biotech Limited has focused on leveraging fermentation technology to produce active pharmaceutical ingredients (APIs) for a variety of therapeutic areas including immunosuppressants, anti-bacterial, oncology, antifungal, and more. Additionally, the company extends its expertise to offering contract research and manufacturing services, specializing in fermentation and semi-synthetic products, thereby playing a critical role in the broader pharmaceutical and biotech industry ecosystems.

Products and Services

• Immunosuppressants: The company produces essential APIs like tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus that are pivotal in the management and treatment of immune system disorders.
• Oncology: Concord Biotech Limited offers a range of products for cancer therapy, including temsirolimus, everolimus, romidepsin, mitomycin, midostaurin, dactinomycin, staurosporin, mitoguazone, and an everolimus premix, showcasing its breadth in providing solutions for various oncological challenges.
• Anti-Bacterial: Addressing the critical need for effective antibacterial treatments, the company supplies APIs such as mupirocin, mupirocin calcium, polymyxin B sulfate, fidaxomicin, vancomycin hydrochloride, and teicoplanin to combat bacterial infections.
• Antifungal: To counter fungal infections, Concord Biotech Limited offers an array of antifungal APIs including anidulafungin, caspofungi, micafungin sodium, amphotericin B, and nystatin, reflecting its comprehensive approach toward infectious diseases.
• Other Therapeutic Areas: The company also markets lovastatin, pravastatin sodium, and various enzymes that cater to different therapeutic needs, illustrating the versatility and depth of its product portfolio.
• Contract Research and Manufacturing Services: Beyond its product offerings, Concord Biotech emphasizes its role as a service provider through contract research and manufacturing services. Specializing in fermentation and semi-synthetic products, it supports partners in bringing high-quality pharmaceutical products to market.